Abstract

Behavioral parent and teacher training and stimulant medication are recommended interventions for children with attention-deficit/hyperactivity disorder (ADHD). However, not all children with ADHD receive this evidence-based care, and the aim of the current study was to find out why. More specifically, we investigated clinicians’ policy, guideline use, and attitudes towards medication and parent training when treating children with ADHD, as well as several factors that could affect this. A total of 219 Dutch clinicians (mainly psychologists, psychiatrists and educationalists) completed a survey. Clinicians were likely to recommend medication more often than parent training, and clinicians’ policy to recommend medication and parent training was positively associated with their attitudes towards these interventions. Less experienced clinicians and those with a non-medical background reported lower rates of guideline use, whereas clinicians with a medical background reported less positive attitudes towards parent training. Furthermore, a substantial portion of the clinicians based their decision to recommend parent training on their clinical judgement (e.g., prior estimations of efficacy, perceived low abilities/motivation of parents), and many clinicians reported barriers for referral to parent training, such as waiting lists or a lack of skilled staff. To achieve better implementation of evidence-based care for children with ADHD, guidelines should be communicated better towards clinicians. Researchers and policy-makers should further focus on barriers that prevent implementation of parent training, which are suggested by the discrepancy between clinicians’ overall positive attitude towards parent training and the relatively low extent to which clinicians actually advise parent training.

Highlights

  • Attention-deficit/hyperactivity disorder (ADHD) is a highly prevalent neurodevelopmental disorder, characterized by excessive and impairing levels of inattention and/or hyperactivity-impulsivity [1, 2]

  • The high levels of impairment associated with untreated ADHD as well as the lower quality of life and adverse outcomes of affected children emphasize the importance of a wide implementation of effective interventions

  • In Tier II, we examined which characteristics of clinicians were related to their guideline use, their attitudes and their policy

Read more

Summary

Introduction

Attention-deficit/hyperactivity disorder (ADHD) is a highly prevalent neurodevelopmental disorder, characterized by excessive and impairing levels of inattention and/or hyperactivity-impulsivity [1, 2]. Relative to their unaffected peers, children with ADHD experience more learning [3] and social problems [4], and their quality of life is generally lower [5]. The high levels of impairment associated with untreated ADHD as well as the lower quality of life and adverse outcomes of affected children emphasize the importance of a wide implementation of effective interventions. Clinicians’ knowledge of, and adherence to guidelines is necessary to increase the use of effective interventions, thereby improving the quality of care for children with ADHD and their parents/caretakers, and reducing societal costs of ADHD [19]

Objectives
Methods
Results
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call